You are here: All Products  > ICT Approved to Start US Trials of CD-19 CAR-T for Lymphoma

ICT Approved to Start US Trials of CD-19 CAR-T for Lymphoma

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products